Troy Grennan

Dr. Troy Grennan is an infectious diseases physician and researcher. He is currently the physician lead for the Provincial HIV/STI Program at the BC Centre for Disease Control, as well as a clinical associate professor in the Division of Infectious Diseases at the University of British Columbia. Following specialty training in infectious diseases and medical microbiology, he completed a Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network postdoctoral fellowship examining human papillomavirus (HPV)-associated anal cancer screening in HIV-positive men who have sex with men (MSM). 

Dr. Grennan is currently co-principal investigator on the CIHR Team Grant “HPV Screening and Vaccine Evaluation in HIV-Positive MSM” and the recently funded “Predicting and Evaluating Anal Cancer in HIV (PEACH) using novel biomarkers,” as well as a number of other projects examining anal cancer screening and HPV vaccination in MSM. His other research and clinical work focuses on HIV and sexually transmitted infection (STI) prevention with a focus on MSM. He is principal Iinvestigator on the DISCO (Doxycycline as an Intervention for STI ChemOprophylaxis) study, a multi-centre randomized controlled trial examining the use of doxycycline for bacterial STI prevention.